Susquehanna International Group
DFTX

Susquehanna International Group’s Definium Therapeutics DFTX Stock Holding History

Susquehanna International Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
81,456
-395,656
-83% -$6.71M ﹤0.01% 6810
2025
Q4 		$6.39M Buy
477,112
+459,839
+2,662% +$5.69M ﹤0.01% 3659
2025
Q3 		$204K Sell
17,273
-152,052
-90% -$1.42M ﹤0.01% 10954
2025
Q2 		$1.1M Sell
169,325
-175,879
-51% -$1.16M ﹤0.01% 7185
2025
Q1 		$2.02M Buy
345,204
+146,784
+74% +$1.05M ﹤0.01% 5521
2024
Q4 		$1.38M Buy
+198,420
New +$1.37M ﹤0.01% 6153
2024
Q2 		– Sell
-269,596
Closed -$2.36M – 12802
2024
Q1 		$2.53M Buy
269,596
+39,545
+17% +$225K ﹤0.01% 4845
2023
Q4 		$842K Buy
230,051
+36,169
+19% +$109K ﹤0.01% 7403
2023
Q3 		$607K Buy
+193,882
New +$797K ﹤0.01% 7771
2023
Q2 		– Sell
-232,027
Closed -$800K – 12735
2023
Q1 		$736K Buy
232,027
+66,232
+40% +$220K ﹤0.01% 7604
2022
Q4 		$365K Buy
+165,795
New +$460K ﹤0.01% 8632
2022
Q3 		– Sell
-42,183
Closed -$405K – 13774
2022
Q2 		$405K Sell
42,183
-3,414
-7% -$43.2K ﹤0.01% 8784
2022
Q1 		$759K Sell
45,597
-24,659
-35% -$428K ﹤0.01% 7857
2021
Q4 		$1.45M Sell
70,256
-490
-0.7% -$15.6K ﹤0.01% 6290
2021
Q3 		$2.47M Sell
70,746
-11,803
-14% -$510K ﹤0.01% 5378
2021
Q2 		$4.27M Buy
+82,549
New +$4.33M ﹤0.01% 4321

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's DFTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Definium Therapeutics (DFTX) stake by 83% in Q1 2026, selling an estimated $6.71M and leaving 81,456 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #6810.

Susquehanna International Group first reported a position in DFTX in Q2 2021 and has held it in 16 quarters since. The position peaked at $6.39M in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Susquehanna International Group held 81,456 shares of Definium Therapeutics worth $1.54M as of Q1 2026.
  • Susquehanna International Group sold 395,656 Definium Therapeutics shares in Q1 2026, an estimated $6.71M.
  • Definium Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6810 holding.
  • Susquehanna International Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Definium Therapeutics position peaked at $6.39M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.